Cancer stem cell metabolism: target for cancer therapy

BMB Rep. 2018 Jul;51(7):319-326. doi: 10.5483/bmbrep.2018.51.7.112.

Abstract

Increasing evidence suggests that cancer stem cell (CSC) theory represents an important mechanism underlying the observed failure of existing therapeutic modalities to fully eradicate cancers. In addition to their more established role in maintaining minimal residual disease after treatment and forming the new bulk of the tumor, CSCs might also critically contribute to tumor recurrence and metastasis. For this reason, specific elimination of CSCs may thus represent one of the most important treatment strategies. Emerging evidence has shown that CSCs have a different metabolic phenotype to that of differentiated bulk tumor cells, and these specific metabolic activities directly participate in the process of CSC transformation or support the biological processes that enable tumor progression. Exploring the role of CSC metabolism and the mechanism of the metabolic plasticity of CSCs has become a major focus in current cancer research. The targeting of CSC metabolism may provide new effective therapies to reduce the risk of recurrence and metastasis. In this review, we summarize the most significant discoveries regarding the metabolism of CSCs and highlight recent approaches in targeting CSC metabolism. [BMB Reports 2018; 51(7): 319-326].

Publication types

  • Review

MeSH terms

  • Glutamine / metabolism
  • Glycolysis
  • Humans
  • Lipid Metabolism
  • Metabolic Networks and Pathways
  • Neoplasm Recurrence, Local
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Neoplastic Stem Cells / cytology
  • Neoplastic Stem Cells / metabolism*
  • Oxidative Phosphorylation
  • Tumor Microenvironment

Substances

  • Glutamine